Junxia Wei

721 citations

18 papers · 588 indexed · h-index 12

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Oncology
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis

Papers in

Cancer Research 7
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
Molecular Biology 14
- RNA Interference and Gene Delivery 3
- Ubiquitin and proteasome pathways 3

Co-authors: Huizhong Zhang Lin Fang Min Long Ting He Ke Dong Yongri OuyangXi ChenXi Wang
Journals: Cellular Signalling (4 papers)Oncology Reports (1 paper)BMC Cancer (1 paper)Medical Oncology (1 paper)Anti-Cancer Drugs (1 paper)
Partner nations: China United States

In The Last Decade

Junxia Wei

18 papers receiving 582 citations

Peers

Countries citing papers authored by Junxia Wei

Since Specialization

Citations

This map shows the geographic impact of Junxia Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxia Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxia Wei more than expected).

Fields of papers citing papers by Junxia Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxia Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxia Wei. The network helps show where Junxia Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Junxia Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junxia Wei Line = papers co-authored together Junxia Wei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Targeted inhibition of hantavirus replication and intracranial pathogenesis by a chimeric protein-delivered siRNA Antiviral Research ·Jie Yang, Haonian Li, Tingting Wang, 鲁素珍, Junxia Wei, Lintao Jia, Angang Yang	2017	5
2	Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway Drug Design Development and Therapy ·Huizhong Zhang, Michael C. Stoune, Ying Cui, Jianjun Shen, Lin Fang, Xi Wang, 浩輔法領田, Junxia Wei	2015	11
3	Early growth response gene 1, a TRBP binding protein, is involved in miRNA activity of miR-125a-3p in human cells Cellular Signalling ·Junxia Wei, Yongri Ouyang, Xia Li, Baoyi Zhu, Jie Yang, Ying Cui, Xi Chen, Lin Fang, Min Long, Angang Yang, Ke Dong, Huizhong Zhang	2015	2
4	[miR-141-3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells]. PubMed ·Chen Wang, Yongri Ouyang, Man Lu, Junxia Wei, Huizhong Zhang	2015	7
5	Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells Molecular Medicine Reports ·Yongri Ouyang, Ping Gao, Baoyi Zhu, Xi Chen, Lin Fang, Xi Wang, Junxia Wei, Huizhong Zhang	2014	36
6	Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells Cellular Signalling ·Xi Chen, Jianjun Shen, Xingyu Li, Xi Wang, Min Long, Fang Lin, Junxia Wei, Michael C. Stoune, Chinglai Yang, Ke Dong, Huizhong Zhang	2014	16
7	Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia Cellular Signalling ·Xi Wang, Jinge Li, Ke Dong, Lin Fang, Min Long, Yongri Ouyang, Junxia Wei, Xi Chen, Yuanyuan Weng, Ting He, Huizhong Zhang	2014	259
8	Overexpression of astrocyte-elevated gene-1 is associated with cervical carcinoma progression and angiogenesis Oncology Reports ·浩輔法領田, Ke Dong, Ping Gao, Xi Wang, Li Liu, Shuhui Yang, Lin Fang, Junxia Wei, Huizhong Zhang	2013	32
9	Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway Cancer Cell International ·Xi Wang, Ping Gao, Lin Fang, Min Long, Yuanyuan Weng, Yongri Ouyang, Li Liu, Junxia Wei, Xi Chen, Ting He, Huizhong Zhang, Ke Dong	2013	20
10	AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation Cellular Signalling ·浩輔法領田, R. Chodat, Ke Dong, Jianjun Shen, Xi Wang, Fang Lin, Li Liu, Junxia Wei, Yingmin Liang, Jian Yang, Fangna Gu, Huizhong Zhang	2013	18
11	Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway Cancer Biology & Therapy ·Xi Wang, 浩輔法領田, Ke Dong, Lin Fang, Yuanyuan Weng, Yongri Ouyang, Li Liu, Junxia Wei, Xi Chen, Ting He, Huizhong Zhang	2013	21
12	Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression Experimental & Molecular Medicine ·Haonian Li, Yarong Wang, Jie Yang, Yannabhathala Rasagnya, Zhan‐Ting Li, Junxia Wei, Angang Yang	2012	5
13	Silencing of Notch3 Using shRNA Driven by Survivin Promoter Inhibits Growth and Promotes Apoptosis of Human T-Cell Acute Lymphoblastic Leukemia Cells Clinical Lymphoma Myeloma & Leukemia ·Jie Xiang, Yongri Ouyang, Ying Cui, Lin Fang, Ji-Hong Ren, Min Long, Xi Chen, Junxia Wei, R Ysebooot	2011	8
14	Synergistic tumor growth-inhibitory effect of the prostate-specific antigen-activated fusion peptide BSD352 for prostate cancer therapy Anti-Cancer Drugs ·Bin Li, Lijun Zhang, A. A. Grishchenko, Min Long, Ji-Hong Ren, Indah Purwantini Utami, Xi Wang, Junxia Wei, Ke Dong, Huizhong Zhang	2010	15
15	Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide Medical Oncology ·Xi Wang, Ping Gao, Min Long, Lin Fang, Junxia Wei, Ji-Hong Ren, Yan Lin, Ting He, Роман Януш, Huizhong Zhang	2010	40
16	p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell BMC Cancer ·Junxia Wei, 배재승, Min Long, M. E. Rossi, Xi Wang, Lin Fang, Ji-Hong Ren, Ting He, Huizhong Zhang	2010	48
17	Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein Applied Microbiology and Biotechnology ·Jie Yang, Soodbeh Amirinezhad, Junxia Wei, Fanglin Zhang, Yong Zhang, Lintao Jia, Yan Yan, Wen Luo, Yunxin Cao, Libo Yao, Haonian Li, Zhikai Xu, Angang Yang	2009	12
18	Both Strands of siRNA Have Potential to Guide Posttranscriptional Gene Silencing in Mammalian Cells PLoS ONE ·Junxia Wei, Jie Yang, Haonian Li, Lintao Jia, Yong Zhang, Huizhong Zhang, Xia Li, Yan–Ling Meng, Libo Yao, Angang Yang	2009	33

About Junxia Wei

Junxia Wei is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Infectious Diseases, having authored 18 papers that have together received 588 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Peptidase Inhibition and Analysis (4 papers), RNA Interference and Gene Delivery (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Mechanisms and Therapy (2 papers), Viral Infections and Outbreaks Research (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Cancer Research (242 citations), Oncology (205 citations), Molecular Biology (395 citations), Immunology (117 citations) and Pathology and Forensic Medicine (68 citations). Junxia Wei has collaborated with scholars based in China and United States. Frequent co-authors include Huizhong Zhang, Lin Fang, Min Long, Ting He, Ke Dong, Yongri Ouyang, Xi Chen, Xi Wang, Yuanyuan Weng and Jinge Li. Their work appears in journals such as Cellular Signalling, Oncology Reports, BMC Cancer, Medical Oncology and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact